Eversheds Sutherland advises Humanwell Healthcare Group on the Acquisition of the assets of Paion AG and Paion Deutschland GmbH including shares in Paion Holdings UK

modern glass fronted office buildingmodern glass fronted office building

Eversheds Sutherland advises Humanwell Healthcare Group on the Acquisition of the assets of Paion AG and Paion Deutschland GmbH including shares in Paion Holdings UK

March 13, 2024

Germany
Germany
Germany
Humanwell Healthcare (Group) Co. Ltd. is a leading Chinese listed pharmaceutical company mainly engaged in the development, manufacture and distribution of drugs in the fields of anaesthesia and analgesics, gynaecological diseases, central nervous system, dermatology and respiratory diseases as well as other drugs used in hospitals.

Humanwell has more than 520 approved drugs worldwide and 350 drug candidates in the pipeline. In 2022, Humanwell generated sales of USD 3.4 billion and a net profit of USD 0.38 billion. Humanwell distributes its products mainly in China, Africa and the USA and exports its products to more than 50 countries.

"The sale of PAION to Humanwell is a success for the insolvency process, as the majority of jobs have been saved and the full and comprehensive continuation of business operations has been secured. I am confident that PAION will be positioned for the future under the umbrella of Humanwell. This result is due to the committed and professional cooperation with managing director Tilmann Bur and the other parties involved in the proceedings," says Dr. Mark Boddenberg, who is accompanying the proceedings as the court-appointed insolvency administrator.

The Eversheds Sutherland team was led by Corporate M&A Partner Hui Zhao, Commercial Partner Christian Ostermöller and Banking & Finance Partner Daniel Ehret. Further team members were Martin Gliewe and Sabrina Rübsam (both Labour Law), Rebecca Flachs Nobrega and Bohan Wan (both Corporate M&A).

 

The materials on the Eversheds Sutherland website are for general information purposes only and do not constitute legal advice. While reasonable care is taken to ensure accuracy, the materials may not reflect the most current legal developments. Eversheds Sutherland disclaims liability for actions taken based on the materials. Always consult a qualified lawyer for specific legal matters. To view the full disclaimer, see our Terms and Conditions or Disclaimer section in the footer. Eversheds Sutherland is a provider of legal and other services operating through various separate and distinct legal entities. For further information about these entities and Eversheds Sutherlands' structure please see the Legal Notice page of this website.

Services

Industries

Key contacts

daniel.ehret@eversheds-sutherland.com(237821670.2) Headshot

Daniel Ehret, LL.M. (UCT, RSA)

Partner

Frankfurt, Germany

MartinGliewe@eversheds-sutherland.com

Martin Gliewe

Counsel

Frankfurt, Germany

SabrinaRubsam@eversheds-sutherland.com

Sabrina Rübsam

Associate

Frankfurt, Germany

Latest Insights

Latest News

Latest Events

131648317_m

legal updates

September 10, 2026

Global Life Sciences & Healthcare Bulletin

Coding in Action

legal updates

September 10, 2026

Hong Kong: PCPD issues further guidance on best practices in the use of age...

Contemporary glass architecture structural framework detail

legal updates

September 10, 2026

EU WEEE Directive Reform: Tighter Rules, Rising Costs

blue-fibre-optics-close-up

legal updates

September 10, 2026

Part 3a of What is the role of Gen AI in Litigation Series

© Eversheds Sutherland 2026. All rights reserved. Eversheds Sutherland is a provider of legal and other services operating through various separate and distinct legal entities. For further information about these entities and Eversheds Sutherlands' structure please see the Legal Notice page of this website.

Eversheds Sutherland is the name and brand under which the members of Eversheds Sutherland Limited (Eversheds Sutherland (International) LLP and Eversheds Sutherland (US) LLP) and their respective controlled, managed and affiliated firms and the members of Eversheds Sutherland (Europe) Limited (each an "Eversheds Sutherland Entity" and together the "Eversheds Sutherland Entities") provide legal or other services to clients around the world. Eversheds Sutherland Entities are constituted and regulated in accordance with relevant local regulatory and legal requirements and operate in accordance with their locally registered names. The use of the name Eversheds Sutherland, is for description purposes only and does not imply that the Eversheds Sutherland Entities are in a partnership or are part of a global LLP. The responsibility for the provision of services to the client is defined in the terms of engagement between the instructed firm and the client. For further information about these Eversheds Sutherland Entities and Eversheds Sutherlands’ structure please see the Legal Notices page of this website. For information on Konexo please also see the Legal Notices page of this website